Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 1299.35 4.00 (0.31%) | NSE 1304.80 10.00 (0.77%) | Trade | Add

BSE Live

Nov 06, 16:01

1299.35 4.00 (0.31%)

Volume

AVERAGE VOLUME

5-Day

5,350

10-Day

16,078

30-Day

9,748

5,099

Prev. Close

1295.35
Open Price

1282.65

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Nov 06, 15:57

1304.80 10.00 (0.77%)

Volume

AVERAGE VOLUME

5-Day

99,076

10-Day

90,108

30-Day

140,605

226,767

Prev. Close

1294.80
Open Price

1289.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1304.80 (122)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Ipca Laboratories (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
Per Share Ratios
Basic EPS (Rs.)	47.77	35.01	18.97	15.42	7.38
Diluted EPS (Rs.)	47.73	35.01	18.97	15.42	7.38
Cash EPS (Rs.)	65.05	49.58	33.39	29.77	20.56
Book Value [ExclRevalReserve]/Share (Rs.)	288.18	248.35	213.04	194.55	179.02
Book Value [InclRevalReserve]/Share (Rs.)	288.18	248.35	213.04	194.55	179.02
Revenue from Operations/Share (Rs.)	367.92	298.63	258.14	250.09	227.19
PBDIT/Share (Rs.)	77.06	59.32	39.34	37.03	24.71
PBIT/Share (Rs.)	60.40	44.89	25.26	23.33	11.77
PBT/Share (Rs.)	59.10	43.39	23.36	21.42	9.24
Net Profit/Share (Rs.)	48.39	35.14	19.31	16.07	7.62
NP After MI And SOA / Share (Rs.)	47.99	35.21	18.97	15.42	7.38
Profitability Ratios
PBDIT Margin (%)	20.94	19.86	15.24	14.80	10.87
PBIT Margin (%)	16.41	15.03	9.78	9.32	5.18
PBT Margin (%)	16.06	14.53	9.04	8.56	4.06
Net Profit Margin (%)	13.15	11.76	7.47	6.42	3.35
NP After MI And SOA Margin (%)	13.04	11.78	7.34	6.16	3.24
Return on Networth/Equity (%)	16.71	14.24	8.90	7.92	4.12
Return on Capital Employed (%)	19.40	16.42	7.69	6.47	3.18
Return on Assets (%)	11.52	9.77	5.81	4.91	2.39
Total Debt/Equity (X)	0.11	0.11	0.18	0.22	0.30
Asset Turnover Ratio (%)	88.38	82.91	79.12	79.71	73.67
Liquidity Ratios
Current Ratio (X)	2.15	2.17	1.93	1.82	1.67
Quick Ratio (X)	1.16	1.19	1.06	0.90	0.81
Inventory Turnover Ratio (X)	3.51	3.52	3.70	3.58	3.42
Dividend Payout Ratio (NP) (%)	16.67	2.84	5.27	0.00	13.54
Dividend Payout Ratio (CP) (%)	12.37	2.01	3.02	0.00	4.92
Earnings Retention Ratio (%)	83.33	97.16	94.73	0.00	86.46
Cash Earnings Retention Ratio (%)	87.63	97.99	96.98	0.00	95.08
Coverage Ratios
Interest Coverage Ratios (%)	46.25	30.06	13.27	12.23	4.66
Interest Coverage Ratios (Post Tax) (%)	46.25	30.06	13.27	12.23	4.66
Valuation Ratios
Enterprise Value (Cr.)	17,785.27	12,498.93	8,587.32	8,359.87	7,810.03
EV/Net Operating Revenue (X)	3.83	3.31	2.64	2.65	2.72
EV/EBITDA (X)	18.27	16.68	17.30	17.89	25.05
MarketCap/Net Operating Revenue (X)	3.77	3.29	2.54	2.49	2.55
Retention Ratios (%)	83.32	97.15	94.72	0.00	86.45
Price/BV (X)	4.83	3.98	3.07	3.20	3.24
Price/Net Operating Revenue	3.77	3.29	2.54	2.49	2.55
Earnings Yield	0.03	0.04	0.03	0.02	0.01